Friday, January 27, 2023 | Back issues
Courthouse News Service Courthouse News Service

Drug Patents

WASHINGTON - Mylan Pharmaceuticals cannot block an exclusive window that the Food and Drug Administration gave Teva Pharmaceuticals to sell a generic version of Cephalon's patented narcolepsy drug, Provigil (modafinil), a federal judge ruled.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.